Galenica acquiring hyperkalemia play Relypsa

Galenica Ltd. (SIX:GALN) said it will acquire Relypsa Inc. (NASDAQ:RLYP) for $32 per share in cash, which values the company at about $1.5 billion. Relypsa markets hyperkalemia treatment Veltassa patiromer,

Read the full 305 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE